Your browser doesn't support javascript.
loading
Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders.
Eum, Seenae; Hill, S Kristian; Alliey-Rodriguez, Ney; Stevenson, James M; Rubin, Leah H; Lee, Adam M; Mills, Lauren J; Reilly, James L; Lencer, Rebekka; Keedy, Sarah K; Ivleva, Elena; Keefe, Richard S E; Pearlson, Godfrey D; Clementz, Brett A; Tamminga, Carol A; Keshavan, Matcheri S; Gershon, Elliot S; Sweeney, John A; Bishop, Jeffrey R.
Afiliación
  • Eum S; Department of Pharmacogenomics, Shenandoah University, Fairfax, VA, USA.
  • Hill SK; Department of Psychology, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.
  • Alliey-Rodriguez N; Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, USA.
  • Stevenson JM; Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
  • Rubin LH; Departments of Neurology, Psychiatry, and Epidemiology, Johns Hopkins University, Baltimore, MD, USA.
  • Lee AM; Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, MN, USA.
  • Mills LJ; Masonic Cancer Center and Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA.
  • Reilly JL; Department of Psychiatry and Behavioral Sciences, Northwestern University, Chicago, IL, USA.
  • Lencer R; Institute of Translational Psychiatry and Otto Creutzfeldt Center for Cognitive and Behavioral Neuroscience, University of Muenster, Muenster, Germany.
  • Keedy SK; Department of Psychiatry and Psychotherapy, University of Luebeck, Luebeck, Germany.
  • Ivleva E; Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, USA.
  • Keefe RSE; Department of Psychiatry, UT Southwestern Medical Center, Dallas, TX, USA.
  • Pearlson GD; Department of Psychiatry, Duke University School of Medicine, Durham, NC, USA.
  • Clementz BA; Departments of Psychiatry and Neuroscience, Yale School of Medicine, Olin Center, Institute of Living, Hartford Healthcare, Hartford, CT, USA.
  • Tamminga CA; Department of Psychology, University of Georgia, Athens, GA, USA.
  • Keshavan MS; Department of Psychiatry, UT Southwestern Medical Center, Dallas, TX, USA.
  • Gershon ES; Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Sweeney JA; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
  • Bishop JR; Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, USA.
Neuropsychopharmacology ; 46(10): 1802-1810, 2021 09.
Article en En | MEDLINE | ID: mdl-34145405
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Esquizofrenia / Disfunción Cognitiva Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Neuropsychopharmacology Asunto de la revista: NEUROLOGIA / PSICOFARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Esquizofrenia / Disfunción Cognitiva Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Neuropsychopharmacology Asunto de la revista: NEUROLOGIA / PSICOFARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos